Comparative Plasma and Interstitial Tissue Fluid Pharmacokinetics of Meropenem Demonstrate the Need for Increasing Dose and Infusion Duration in Obese and Non-obese Patients.

Clin Pharmacokinet · 2022 · PMC9095536 · PMID 34894344

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a small trendno p-value reported

A small trend of underpredicting low meropenem plasma concentrations in obese patients and overpredicting low concentrations in non-obese patients remained (Fig.

also in 722 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.